MONTREAL, Oct. 2 /CNW Telbec/ - For the occasion, more than
1,200 participants from throughout the world will meet at the Château
Frontenac from October 3rd to the 5th. "Stemming from 150 major investment
corporations as well as from the biopharmaceutical industry, companies and
researchers will gather to discuss and participate in a series of conferences
and individual sessions" mentioned Martin Godbout, president of Génome Canada
and founder of the event.
During three days, participants will present their latest research and
ongoing projects in the following fields: cancer, cardiology, endocrinology,
genomics and proteomics, neurobiology, immunology, medical technologies and
The 2007 edition of BioContact Québec will welcome renowned speakers such
as Mr. Francis S. Collins, M.D., Ph.D., director of the National Human Genome
Research Institute. Dr. Collins will also be the guest speaker for the
symposium opening dinner held tomorrow at noon in the ballroom of the Château
Frontenac. Take note that the 14th BioContact symposium will also feature
Mr. Tom Finn, president "Global Health Care" of Procter & Gamble, and Mr.
Simon Gill, from RBC Capital Markets.
For further information:
For further information: Hélène Turcotte, BioContact 2007, (418)